4
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Rare Pulmonary Neuroendocrine Cells Are Stem Cells Regulated by Rb, p53, and Notch

      , , , , ,
      Cell
      Elsevier BV

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Pulmonary neuroendocrine (NE) cells are neurosensory cells sparsely distributed throughout the bronchial epithelium, many in innervated clusters of 20–30 cells. Following lung injury, NE cells proliferate and generate other cell types to promote epithelial repair. Here we show that only a subpopulation of NE cells, typically 2–4 cells per cluster, function as stem cells. These differentiated cells display the key features of classical stem cells. Most proliferate (self-renew) following injury, and some migrate into the injured area. Rare cells, often just one per cluster, lose NE identity, transit amplify, and reprogram to other fates, creating a large clonal patch of regenerated epithelium. Small cell lung cancer (SCLC) tumor suppressors regulate the stem cell program: Rb/p53 suppress self-renewal, whereas Notch initiates deprogramming and transit amplification. We propose that NE stem cells are tumor-initiating cells for SCLC, and transformation results from constitutive activation of stem cell renewal and inhibition of deprogramming.

          Related collections

          Author and article information

          Journal
          Cell
          Cell
          Elsevier BV
          00928674
          October 2019
          October 2019
          : 179
          : 2
          : 403-416.e23
          Article
          10.1016/j.cell.2019.09.010
          6782070
          31585080
          c14ea6b7-d4bd-4711-9ff6-183a6c24b919
          © 2019

          https://www.elsevier.com/tdm/userlicense/1.0/

          History

          Comments

          Comment on this article